Anti-Siglec-8 Antibody (Lirentelimab)
Catalog No.
F1077
Anti-Siglec-8 Antibody (Lirentelimab)
Featured Products
Lirentelimab (AK002) is a humanizedIgG1 Monoclonal antibody targeting sialic acid-binding Ig-like lectin 8 (SIGLEC8 ). Lirentelimab-inducedIL-5 Activated eosinophilsApoptosis and inhibitIL-5 Mediated mast cell activation. Lirentelimab can be used in the study of eosinophilic gastritis and duodenitis.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
2283348-97-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
AK 002, Lirentelimab, AK-002
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NYZ4
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Siglec-8
Please avoid freeze-thaw cycles.